Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

被引:27
|
作者
Talaei, Mohammad [1 ]
Faustini, Sian [2 ]
Holt, Hayley [1 ,3 ,4 ]
Jolliffe, David A. [1 ,3 ]
Vivaldi, Giulia [1 ,3 ]
Greenig, Matthew [1 ]
Perdek, Natalia [1 ]
Maltby, Sheena [1 ]
Bigogno, Carola M. [1 ]
Symons, Jane [5 ]
Davies, Gwyneth A. [6 ]
Lyons, Ronan A. [6 ]
Griffiths, Christopher J. [1 ,4 ]
Kee, Frank [7 ]
Sheikh, Aziz [8 ]
Richter, Alex G. [2 ]
Shaheen, Seif O. [1 ]
Martineau, Adrian R. [1 ,3 ,4 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Populat Hlth, London, England
[2] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Queen Mary Univ London, Asthma UK Ctr Appl Res, London, England
[5] Jane Symons Media, London, England
[6] Swansea Univ, Med Sch, Populat Data Sci, Singleton Pk, Swansea, W Glam, Wales
[7] Queens Univ Belfast, Ctr Publ Hlth Res NI, Belfast, Antrim, North Ireland
[8] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland
基金
英国科研创新办公室;
关键词
SARS-CoV-2; Serology; Ethnicity; Diet; Micronutrients; Lifestyle; Exercise; Obesity; Alcohol; Occupation; INFECTION;
D O I
10.1186/s12916-022-02286-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited between May 1 and November 2, 2020, without a positive swab test result for SARS-CoV-2 prior to enrolment. Information on 88 potential sociodemographic, behavioural, nutritional, clinical and pharmacological risk factors was obtained through online questionnaires, and combined IgG/IgA/IgM responses to SARS-CoV-2 spike glycoprotein were determined in dried blood spots obtained between November 6, 2020, and April 18, 2021. We used logistic and linear regression to estimate adjusted odds ratios (aORs) and adjusted geometric mean ratios (aGMRs) for potential determinants of SARS-CoV-2 seropositivity (all participants) and antibody titres (seropositive participants only), respectively. Results Of 11,130 participants, 1696 (15.2%) were seropositive. Factors independently associated with higher risk of SARS-CoV-2 seropositivity included frontline health/care occupation (aOR 1.86, 95% CI 1.48-2.33), international travel (1.20, 1.07-1.35), number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.29, 1.06-1.57, P-trend = 0.01), body mass index (BMI) >= 25 vs. < 25 kg/m(2) (1.24, 1.11-1.39), South Asian vs. White ethnicity (1.65, 1.10-2.49) and alcohol consumption >= 15 vs. 0 units/week (1.23, 1.04-1.46). Light physical exercise associated with lower risk (0.80, 0.70-0.93, for >= 10 vs. 0-4 h/week). Among seropositive participants, higher titres of anti-Spike antibodies associated with factors including BMI >= 30 vs. < 25 kg/m(2) (aGMR 1.10, 1.02-1.19), South Asian vs. White ethnicity (1.22, 1.04-1.44), frontline health/care occupation (1.24, 95% CI 1.11-1.39), international travel (1.11, 1.05-1.16) and number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.12, 1.02-1.23, P-trend = 0.01); these associations were not substantially attenuated by adjustment for COVID-19 disease severity. Conclusions Higher alcohol consumption and lower light physical exercise represent new modifiable risk factors for SARS-CoV-2 infection. Recognised associations between South Asian ethnic origin and obesity and higher risk of SARS-CoV-2 seropositivity were independent of other sociodemographic, behavioural, nutritional, clinical, and pharmacological factors investigated. Among seropositive participants, higher titres of anti-Spike antibodies in people of South Asian ancestry and in obese people were not explained by greater COVID-19 disease severity in these groups.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Evidence of rapid rise in population immunity from SARS-CoV-2 subclinical infections through pre-vaccination serial serosurveys in Pakistan
    Iqbal, Junaid
    Hasan, Zahra
    Habib, Muhammad Atif
    Malik, Asma Abdul
    Muhammad, Sajid
    Begum, Kehkashan
    Zuberi, Rabia
    Umer, Muhammad
    Ikram, Aamer
    Soofi, Sajid Bashir
    Cousens, Simon
    Bhutta, Zulfiqar A.
    JOURNAL OF GLOBAL HEALTH, 2025, 15
  • [42] Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey
    Luk, Tzu Tsun
    Zhao, Shengzhi
    Wu, Yongda
    Wong, Janet Yuen-ha
    Wang, Man Ping
    Lam, Tai Hing
    VACCINE, 2021, 39 (27) : 3602 - 3607
  • [43] Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study
    Balck, Alexander
    Foeh, Bandik
    Borsche, Max
    Rahmoeller, Johann
    Vollstedt, Eva-Juliane
    Waldeck, Frederike
    Kaeding, Nadja
    Twesten, Christoph
    Mischnik, Alexander
    Gillessen-Kaesbach, Gabriele
    Ehlers, Marc
    Sina, Christian
    Taube, Stefan
    Busch, Hauke
    Rupp, Jan
    Katalinic, Alexander
    Klein, Christine
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [44] Vaccination against SARS-CoV-2 infection among vulnerable and marginalised population groups in Denmark: A nationwide population-based study
    Nilsson, Sandra Feodor
    Laursen, Thomas Munk
    Osler, Merete
    Hjorthoj, Carsten
    Benros, Michael E.
    Ethelberg, Steen
    Molbak, Kare
    Nordentoft, Merete
    LANCET REGIONAL HEALTH-EUROPE, 2022, 16
  • [45] Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study – a prospective population-based cohort study
    Alexander Balck
    Bandik Föh
    Max Borsche
    Johann Rahmöller
    Eva-Juliane Vollstedt
    Frederike Waldeck
    Nadja Käding
    Christoph Twesten
    Alexander Mischnik
    Gabriele Gillessen-Kaesbach
    Marc Ehlers
    Christian Sina
    Stefan Taube
    Hauke Busch
    Jan Rupp
    Alexander Katalinic
    Christine Klein
    BMC Public Health, 22
  • [46] Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study
    Schaffner, Anna
    Risch, Lorenz
    Weber, Myriam
    Thiel, Sarah
    Juengert, Katharina
    Pichler, Michael
    Wohlwend, Nadia
    Lung, Thomas
    Ritzler, Michael
    Hillmann, Dorothea
    Copeland, Sandra
    Renz, Harald
    Paprotny, Matthias
    Risch, Martin
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (02) : E49 - E51
  • [47] Predictors of seropositivity against SARS-COV-2: a population-based seroepidemiological study
    Musheghyan, L.
    Sahakyan, S.
    Sargsyan, Z.
    Muradyan, D.
    Aslanyan, L.
    Gharibyan, N.
    Harutyunyan, A.
    Khachadourian, V.
    Petrosyan, V.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [48] Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination
    Montmaneix-Engels, Faustine
    Dimeglio, Chloe
    Staes, Laeticia
    Da Silva, Isabelle
    Porcheron, Marion
    Jougla, Isabelle
    Herin, Fabrice
    Izopet, Jacques
    HELIYON, 2024, 10 (07)
  • [49] Seroprevalence of anti-SARS-CoV-2 in patients with hepatitis B and C: a pre-vaccination study
    Silva, Lucas Lima da
    Lewis-Ximenez, Lia Laura
    Magalhaes, Monica de Avelar Figueiredo Mafra
    de Paula, Vanessa Salete
    Villar, Livia Melo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2024, 28 (03):
  • [50] Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection
    Keijzer, Sofie
    Oskam, Nienke
    Ooijevaar-de Heer, Pleuni
    Steenhuis, Maurice
    Keijser, Jim B. D.
    Wieske, Luuk
    van Dam, Koos P. J.
    Stalman, Eileen W.
    Kummer, Laura Y. L.
    Boekel, Laura
    Kuijpers, Taco W.
    ten Brinke, Anja
    van Ham, S. Marieke
    Eftimov, Filip
    Tas, Sander W.
    Wolbink, Gerrit J.
    Rispens, Theo
    FRONTIERS IN IMMUNOLOGY, 2024, 15